Jonas Paludo

61PUBLICATIONS
205CO-AUTHORS
Haematological tumoursPredictive and prognostic markersMedical mycologyCancer therapy (excl. chemotherapy and radiation therapy)Medical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (61)

|Jan 07, 2026
POD24 is a novel determinant of prognosis in patients with Waldenström macroglobulinemia.

Saurabh Zanwar, Jithma Abeykoon, Shirley D'Sa

|Nov 22, 2025
The ratio of brain to liver glucose activity and prognosis with CAR-T in non-Hodgkin lymphoma.

Sarah Dingli, Paul Rothweiler, Stephen M Ansell

|May 01, 2025
Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell Lymphoma.

Michael Wang, David Salek, David Belada

|Mar 10, 2025
Depth of Response From Fixed-Duration Treatment Is Associated With Superior Survival in Waldenstrom Macroglobulinemia.

Jonas Paludo, Jithma P Abeykoon, Nirosha D Perera

Pageof 11